Literature DB >> 11317625

Pulmonary embolism after intravenous immunoglobulin.

C Alliot1, J P Rapin, M Besson, F Bedjaoui, D Messouak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11317625      PMCID： PMC1281394          DOI： 10.1177/014107680109400412

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  4 in total

Review 1.  Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications.

Authors:  R S Go; T G Call
Journal:  Mayo Clin Proc       Date:  2000-01       Impact factor: 7.616

2.  Autoimmune cytopenias associated with malignancies and successfully treated with intravenous immune globulins: about two cases.

Authors:  C Alliot; M Barrios; S Tabuteau; B Desablens
Journal:  Therapie       Date:  2000 May-Jun       Impact factor: 2.070

3.  High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events.

Authors:  M C Dalakas
Journal:  Neurology       Date:  1994-02       Impact factor: 9.910

4.  Complications of intravenous immune globulin treatment in neurologic disease.

Authors:  T H Brannagan; K J Nagle; D J Lange; L P Rowland
Journal:  Neurology       Date:  1996-09       Impact factor: 9.910
  4 in total
  2 in total

Review 1.  On the dark side of therapies with immunoglobulin concentrates: the adverse events.

Authors:  Peter J Späth; Guido Granata; Fabiola La Marra; Taco W Kuijpers; Isabella Quinti
Journal:  Front Immunol       Date:  2015-02-05       Impact factor: 7.561

2.  Effect of Age on the Protein Profile of Healthy Malay Adults and its Association with Cognitive Function Competency.

Authors:  Zulzikry Hafiz Abu Bakar; Hanafi Ahmad Damanhuri; Suzana Makpol; Wan Mohd Aizat Wan Kamaruddin; Nur Fathiah Abdul Sani; Ahmad Imran Zaydi Amir Hamzah; Khairun Nain Nor Aripin; Mohd Dzulkhairi Mohd Rani; Nor Azila Noh; Rosdinom Razali; Musalmah Mazlan; Hamzaini Abdul Hamid; Mazlyfarina Mohamad; Wan Zurinah Wan Ngah
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.